Firefly Neuroscience, Inc. held its annual meeting on October 27, 2025, where stockholders approved four key proposals, including the appointment of directors and amendments to the long-term incentive plan. They also adjourned further voting on a proposal to increase authorized shares to a total of 5,001,000,000, which will be voted on again at a reconvened meeting on October 31, 2025.